demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 severe or critically
hydroxychloroquine REMAP-CAP-HCQ HYDRA ... Sarhan Sarhan Mahevas Yu

1 studies excluded by filtering options 2

5864 HYDRA, 2020 210excludedrisk of bias not avaialble